Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Apollo Hospitals - No.1 Indian Heart Hospital as per latest Newsweek survey

Posted On: 2021-09-28 22:29:38 (Time Zone: IST)

Apollo Hospitals today announced the national launch of an AI (artificial intelligence) tool to predict risk of cardiovascular disease. The Apollo AI-powered Cardiovascular Disease Risk tool will help healthcare providers to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference. The cardiac risk scoring tool is remarkable for the speed in processing data and its accuracy at predicting the probability of a patient developing coronary disease. Using the tool, physicians will be enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals, improving lives while mitigating future pressure on healthcare systems.

On the occasion, Apollo Hospitals also announced that it has found pride of place in the Best Specialized Hospitals 2022 ranking released by Newsweek, the premier international news magazine and website. The ranking in partnership with global research firm Statista ranks the world's best specialized hospitals and features the top 250 hospitals for cardiology and oncology and the top 150 for paediatrics among ten specialities. The Apollo Heart Centre at Apollo Hospitals, Chennai makes it to the list of Best Specialized Hospitals 2022 - Cardiology with a global rank of 126 and ranks No. 1 among the five Indian hospitals in the list.

Also, in the Best Specialized Hospitals 2022 - Oncology, two hospitals from the Apollo Hospitals Group make it to the list with Apollo Cancer Centres at Apollo Speciality Cancer Hospital, Chennai and Apollo Hospitals, Chennai ranked at 228 and 239 respectively. The two hospitals are among just four Indian hospitals that are in list for Oncology. In the Paediatric speciality, Apollo Children's Hospital, Chennai ranked at 103 globally and one among just five Indian hospitals that are part of the Best Specialized Hospitals 2022 - Paediatrics ranking.

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, "The nation's economy is intricately linked to the health of the people with non-communicable diseases (NCDs) leading to loss of productivity with a consequent impact on national income.

While estimates suggest that NCDs account for an economic burden in the range of 5% to 10% of GDP, it is the chronic nature of NCDs, and their projected increase in prevalence, that will result in a growing economic impact if not addressed in time. Among the rising burden of NCDs, cardiovascular diseases (CVDs) figure at the top. Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as our populations continue to age. It's also a problem that healthcare providers struggle to diagnose early enough to make a real difference.

"While some predictive tools do exist to help physicians understand the probability of their patients developing heart disease, most of these are based on Western data sets and don't take regional risk variations into account. This impacts their accuracy when applied in an Indian context. The Apollo AI-powered Cardiovascular Disease Risk tool will change that and put the knowledge and the means to predict and prevent heart disease in the physician's hands. Available till now only to Apollo's physicians, it is a proud moment for us to dedicate this AI tool to all physicians in the country."

Speaking on the Newsweek recognition, Dr. Prathap C Reddy added, "This global recognition is testament to the specialty healthcare of international standards provided at Apollo Hospitals with outcomes matching those of the world's best hospitals. Apollo Hospitals, with some of the world's finest and brightest medical experts, has been the pioneer in bringing ground-breaking healthcare technologies to India to deliver best in class clinical results."

The team at Apollo Hospitals collected more than ten years of data relating to 400,000 individuals across the country. Then, they used Microsoft Azure to turn that anonymized data into actionable insights that data scientists and clinicians could use to train machine learning models. The tool has been validated using data from the Maastricht Study, a long-term cohort health study in the Maastricht region and from the Heart+Vascular Center at Maastricht University Medical Center, Netherlands.

Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, "The AI tool to predict and prevent heart disease is the fruition of many years of research and development and stands testament to Apollo Hospitals' technological prowess. Apollo's AI-powered Cardiovascular Disease Risk Score is specifically for use in the Indian population, so physicians can better predict the risk of cardiac disease in their patients. The tool is built on algorithms based on ten years of anonymized data relating to around 400,000 individuals across the country collected by the team at Apollo Hospitals.

"The tool has also been validated internationally using federated learning through Microsoft Azure Platform. Doctors across the Apollo network have been leveraging this AI-powered tool for three years to predict risk of cardiovascular disease and drive preventive cardiac care across the country. With this launch of the AI tool to predict risk of heart disease, we will be able to help achieve the World Health Organization's goal of reducing the risk of premature mortality from non-communicable diseases, including CVDs, by 25% by 2025."

The AI-powered tool delivers a more accurate CVD risk score using algorithms specifically for the Indian population and helps in developing standardised care regimens. Developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events, the tool delivers a risk score that takes into account all contributing factors including lifestyle attributes such as diet, tobacco & smoking preferences and physical activity as well as psychological stress and anxiety as reflected via rate of respiration, and hypertension. The risk is categorized into High, Moderate and Minimal. The tool also gives insights on the risk contributors that can be modified to improve the score. This enables physicians to give a more holistic advice to their patients with specific insights for lifestyle modification.

Shares of Apollo Hospitals Enterprises Ltd., was last trading in BSE at Rs. 4411.75 as compared to the previous close of Rs. 4565.75. The total number of shares traded during the day was 148023 in over 9022 trades.

The stock hit an intraday high of Rs. 4644 and intraday low of 4376.4. The net turnover during the day was Rs. 659945858.

Click here to send ur comments or to

Other Headlines:

SecureKloud Technologies Limited allots 2,84,000 shares on conversion of warrants

IEX to commence trade in Energy Saving Certificates under PAT Cycle- II on 26 October 2021

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination

Godrej Properties in partnership with Dasra Launches report

EOS Data Analytics Partners up with Cambridge Technology in the agriculture and forestry sectors

Balu Forge Industries Ltd Board to consider Interim Dividend for FY22

Karda Constructions Ltd announces Q2FY22 results

ICRA Ltd reports consolidated PAT of Rs. 24.05 crore in Q2FY22

IndiGo partners Kotak Mahindra Bank for Ka-ching co-branded credit card

Apollo Hospitals announces free COVID vaccinations for children with Co-Morbidities

Bharat Petroleum to strengthen rural market connect with launch of new campaign by MAK Lubricants

ANG Lifesciences India Ltd board declares interim dividend of Rs. 1

Home First Finance Company India Limited - Highlights for Q2FY22

Advitiya Trade India Ltd to consider migration to main board of BSE

Quick Heal Technologies Ltd Q2FY22 consolidated PAT at Rs. 34.62 crore

ANG Life Sciences India Ltd H1FY22 consolidated PAT zooms to Rs. 33.77 crore

Jagran Prakashan Ltd posts consolidated net profit of Rs. 61.83 crore in Q2FY22

Choksi Imaging Ltd posts Rs. 46.46 lakhs net profit in Q2FY22

CEAT Ltd consolidated Q2FY22 net profit climbs QoQ to Rs. 41.98 crore

Sheetal Diamonds Ltd Q2FY22 loss at Rs. 40.44 lakhs

Orbit Exports Ltd Q2FY22 consolidated net profit higher at Rs. 4.54 crore

Indus Towers Ltd reports Rs. 1558.5 crore consolidated profit in Q2FY22

Sagar Productions Ltd posts Rs. 11.26 lakhs PAT in Q2 FY2021-22

Orient Cement Ltd reports Rs. 56.88 crore profit in Q2 FY22

Shreenath Investment Company Ltd Q2FY22 PAT slides to Rs. 5.61 lakhs

Home First Finance Company India Ltd posts Rs. 44.86 crore PAT in Q2 FY2021-22

Hardcastle and Waud Mfg Co. Ltd. Q2FY22 profit jumps to Rs. 69.41 lakhs

LKP Securities Ltd Q2FY22 consolidated net profit at Rs. 3.80 crore

Mangalam Organics Limited to double Camphor production capacity to 10,000 MTPA

Dwarikesh Sugar Industries Ltd - Q2FY22 Highlights

Kansai Nerolac Paints Ltd board declares interim dividend of Rs. 1.25

Mangalam Organics Ltd Q2FY22 consolidated PAT jumps to Rs. 22.31 crore

Mahan Industries Ltd posts loss in Q2FY22

Vardhman Special Steels Ltd Q2FY22 PAT drops QoQ to Rs. 24.29 crore

HDFC Asset Management Company Ltd posts Q2FY22 net profit of Rs. 344.38 crores

Tech Mahindra Ltd board declares special dividend of Rs. 15

TCS Named a Leader in IDC MarketScape for Worldwide Artificial Intelligence IT Services

SunEdison Infrastructure Ltd forms subsidiary

Rama Steel Tubes Limited wins Business Excellence Award of the Year

Maharashtra Scooters Ltd Q2FY22 PAT zooms to Rs. 135.70 crores

Tech Mahindra Ltd consolidated Q2FY22 net profit slips QoQ to Rs. 1338.7 crore

Bigbloc Construction Ltd Q2FY22 consolidated PAT at Rs. 3.14 crore

Kansai Nerolac Paints Ltd reports consolidated PAT of Rs. 92.01 crore, down QoQ, YoY

Shriram Asset Management Company Ltd Q2FY22 net profit at Rs. 19.54 lakhs

The Ugar Sugar Works Ltd starts sugar crushing for 2021-22 season

Aurionpro Solutions Ltd Q2FY22 consolidated PAT up at Rs. 19.57 crore

Dwarikesh Sugar Industries Ltd Q2 FY2021-22 net profit rises to Rs. 39.62 crore

Som Datt Finance Corporation Limited Q2FY22 net profit drops QoQ to Rs. 1.75 crore

GMDC posts consolidated PAT of Rs. 40.45 crore in Q2FY22

Tilak Ventures Ltd Q2FY22 net profit at Rs. 21.53 lakhs

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020